Hydroxyurea Capsules 200 mg, 300 mg, 400 mg and Myelosuppression
Result of checking the interaction of drug Hydroxyurea Capsules 200 mg, 300 mg, 400 mg and disease Myelosuppression for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of hydroxyurea is contraindicated in patients with marked myelosuppression. Hydroxyurea induces myelosuppression, primarily leukopenia. Thrombocytopenia and anemia occur less frequently. Patients should be instructed to immediately report any signs or symptoms suggesting bone marrow suppression such as fever, sore throat, local infection, or bleeding. Close clinical monitoring of hematopoietic function is recommended. Hydroxyurea should not be administered if the white blood cell count falls below 2500/mm3 and/or the platelet count falls below 100,000/mm3, or in the presence of severe anemia.
- "Product Information. Hydrea (hydroxyurea)." Bristol-Myers Squibb, Princeton, NJ.
Generic Name: hydroxyurea
Brand Name: Droxia, Hydrea, Mylocel, Siklos
Synonyms: Hydroxyurea
Hydroxyurea Capsules 200 mg, 300 mg, 400 mg - mielosupresja 
Hydroxyurea Capsules 200 mg, 300 mg, 400 mg - mielossupressão 
Hydroxyurea Capsules 200 mg, 300 mg, 400 mg - myelosuppression 
Hydroxyurea Capsules 200 mg, 300 mg, 400 mg - myelosuppression 
Hydroxyurea Capsules 200 mg, 300 mg, 400 mg - mielosoppressione 
Hydroxyurea Capsules 200 mg, 300 mg, 400 mg - myélosuppression 
Hydroxyurea Capsules 200 mg, 300 mg, 400 mg - Myelosuppression 
Hydroxyurea Capsules 200 mg, 300 mg, 400 mg - mielosupresión 
Hydroxyurea Capsules 200 mg, 300 mg, 400 mg - миелосупрессия 
Hydroxyurea Capsules 200 mg, 300 mg, 400 mg - miyelosüpresyon 
Hydroxyurea Capsules 200 mg, 300 mg, 400 mg - كبت نقي العظم 
Hydroxyurea Capsules 200 mg, 300 mg, 400 mg - 骨髓抑制